Growth Metrics

Fulgent Genetics (FLGT) Share-based Compensation (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Share-based Compensation for 10 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 10.88% to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.6 million through Dec 2025, down 11.01% year-over-year, with the annual reading at $39.6 million for FY2025, 11.01% down from the prior year.
  • Share-based Compensation hit $9.3 million in Q4 2025 for Fulgent Genetics, down from $9.7 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $11.6 million in Q2 2024 to a low of $3.0 million in Q1 2021.
  • Historically, Share-based Compensation has averaged $8.8 million across 5 years, with a median of $10.0 million in 2022.
  • Biggest five-year swings in Share-based Compensation: soared 226.48% in 2021 and later dropped 13.72% in 2025.
  • Year by year, Share-based Compensation stood at $5.0 million in 2021, then soared by 99.64% to $10.0 million in 2022, then increased by 14.07% to $11.4 million in 2023, then dropped by 8.96% to $10.4 million in 2024, then dropped by 10.88% to $9.3 million in 2025.
  • Business Quant data shows Share-based Compensation for FLGT at $9.3 million in Q4 2025, $9.7 million in Q3 2025, and $10.0 million in Q2 2025.